How the FDA's hearing with CBD executives might affect the sector



FDA officials hear from executives at CBD companies, advocacy groups and researchers during an all-day meeting. CNBC’s Aditi Roy reports what that means for the CBD industry.

source

Comments are closed, but trackbacks and pingbacks are open.